🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Applied Biologics clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA register with Applied Biologics as lead sponsor. Synced 27 Sep 2026
4Current trials
4Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Applied Biologics is the lead sponsor of 4 current clinical trials in our USA register. 4 are recruiting patients now. The most common phase is Phase 4. The most-studied condition is Diabetic Foot.

ClinicalTrials.gov trials by status

  • Recruiting4100%

Trials by phase

  • Phase 4250%
  • Not applicable125%
  • Observational125%
01

Clinical trials sponsored by Applied Biologics

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers
NCT07126886 · Pressure Ulcer, Ulcer, Pressure, Pressure Wound
Phase 4 Recruiting 2025-06 USA
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
NCT07159282 · Diabetic Foot, Foot Ulcer, Ulcer Foot
Phase 4 Recruiting 2025-08 USA
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
NCT06564831 · ClinicalTrials.gov ↗ · Diabetic Foot Ulcer, Diabetic Foot, Foot Ulcer
Not applicable Recruiting 2024-09 USA
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.
NCT07360418 · ClinicalTrials.gov ↗ · Diabetic Foot Ulcers (DFU), Foot Ulcer Chronic, Ulcer
Observational Recruiting 2025-10 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Applied Biologics trials

12 conditions
Diabetic Foot2Foot Ulcer2Ulcer Foot2Diabetic Foot Ulcer2Pressure Ulcer1Ulcer, Pressure1Pressure Wound1Pressure Area1DFU1Diabetic Foot Ulcers (DFU)1Foot Ulcer Chronic1Ulcer1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA44

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Diabetic Foot

SponsorTrials
Reprise Biomedical1

Sponsors with the most current trials registered for this condition.

05

Questions about Applied Biologics trials

How many clinical trials does Applied Biologics sponsor?

Applied Biologics is the lead sponsor of 4 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Applied Biologics trials recruiting?

Yes. 4 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.